Search

Author/Creator Armuzzi, A

22. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018)

Authors:
Chaparro, M; Verreth, A; Lobaton, T; Gravito‐Soares, E; Julsgaard, M; Savarino, E; Magro, F; Biron, Avni I; Lopez‐Serrano, P; Casanova, M J; Gompertz, M; Vitor, S; Arroyo, M; Pugliese, D; Zabana, Y; Vicente, R; Aguas, M; Shitrit, Bar‐Gil A; Gutierrez, A; Doherty, G A
Journal:
American journal of gastroenterology
Issue:
Volume 113:Number 3(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. OC-072 Differences in therapy approaches and outcomes in paediatric and adult onset crohn's disease with perianal fistula: comparison of 2 ecco collaborative multicentre fistula cohorts. (17th June 2017)

Authors:
Tzivinikos, C; Nair, M; Ashton, K; Drskova, T; Sahnan, K; Muhammed, R; Devadason, D; Hradsky, O; Crook, K; Palmer, R; Akbar, A; Thomson, M; Hart, A; Fiorino, G; Black, C; Pugliese, D; Armuzzi, A; Katsanos, K; Christodoulou, D; Maconi, G
Journal:
Gut
Issue:
Volume 66(2017)Supplement 2
Page Start:
A39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study. (15th January 2020)

Authors:
Colombel, J F; Panés, J; D'Haens, G; Schreiber, S; Panaccione, R; Peyrin-Biroulet, L; Loftus, E V; Danese, S; Louis, E; Armuzzi, A; Ferrante, M; Vogelsang, H; Lefebvre, J; Doan, T; Xie, W; Huang, B; Petersson, J; Kalabic, J; Robinson, A; Sandborn, W J
Journal:
Journal of Crohn's and colitis
Issue:
Volume 14(2020)Supplement 1
Page Start:
S001
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. OP022 Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: data from the CELEST study. (16th January 2018)

Authors:
Schreiber, S; Peyrin-Biroulet, L; Boland, B; Higgins, P D; Armuzzi, A; Terdiman, J; Zhou, W; Alperovich, G; Cataldi, F; Goteti, S; Lacerda, A P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S015
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. OP0239 Histological features of joint and colonic inflammation in inflammatory bowel disease patients treated with anti-tnf. (15th June 2017)

Authors:
Alivernini, S; Pugliese, D; Tolusso, B; Petricca, L; Bui, L; Guidi, L; Rapaccini, GL; Federico, F; Ferraccioli, G; Armuzzi, A; Gremese, E
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. OP033 The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme. (16th January 2018)

Authors:
Sands, B E; Taub, P R; Feagan, B G; Armuzzi, A; Friedman, G S; Moscariello, M; Lawendy, N; Pedersen, R D; Chan, G; Nduaka, C I; Quirk, D; Salese, L; Su, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S023
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

28. OP14 Prevention of postoperative recurrence of Crohn's disease with vedolizumab: First results of the prospective placebo-controlled randomised trial REPREVIO. (30th January 2023)

Authors:
D'Haens, G; Taxonera, C; Lopez-Sanroman, A; Nos Mateu, P; Danese, S; Armuzzi, A; Roblin, X; Peyrin-Biroulet, L; West, R; Witteman, B; Duijvestein, M; Gecse, K; Hulshoff, M; Mostafavi, N; Clasquin, E; Bouhnik, Y; Laharie, D
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

30. OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM. (25th January 2019)

Authors:
Yzet, C; Ungaro, R; Bossuyt, P; Baert, F; Vanasek, T; D'Haens, G; Joustra, V; Panaccione, R; Novacek, G; Armuzzi, A; Golovchenko, O; Prymak, O; Goldis, A; Travis, S; Hébuterne, X; Ferrante, M; Rogler, G; Fumery, M; Danese, S; Rydzewska, G
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S024
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗